Clinical Research News
-
Alphamab starts phase I clinical trial in Australia
Clinical Research | News | 0 Comment | 11 Oct, 2018
Alphamab Oncology has announced that its proprietary humanized PD-L1 - CTLA-4 bispecific antibody program, the first of its class, has recently started phase I clinical trial in Australia. ...Read more
-
Yisheng receives approval for rabies vaccine clinical study
Clinical Research | News | 0 Comment | 10 Oct, 2018
Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immune modulator biotherapeutics and vaccines, has announce...Read more
-
Eisai receives FDA approval for antiepileptic drug
Clinical Research | News | 0 Comment | 01 Oct, 2018
Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration (FDA) for an indication expansion for Eisai's antiepileptic dr...Read more
-
Atox Bio announces completion of pre-planned safety review
Clinical Research | News | 0 Comment | 25 Sep, 2018
Atox Bio, a clinical stage biotechnology company developing novel therapies for critically ill patients has announced that the independent Data Monitoring Committee (DMC) has completed its ...Read more
-
Immutep collaborates with Merck, Pfizer for Efti
Clinical Research | News | 0 Comment | 25 Sep, 2018
Immutep Limited has announced that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc., to evaluate the combination o...Read more
-
Proxima Clinical Research appoints David Novotny as CSO
Clinical Research | News | 0 Comment | 24 Sep, 2018
David T. Novotny was recently named Chief Strategy Officer (CSO) of Proxima Clinical Research, Inc., a leader in clinical trial and strategic services. Mr. Novotny will be a member of the e...Read more
-
Clinical Research | Opinion | By Priyanka Bajpai | 0 Comment | 20 Sep, 2018
Excerpts from the interview In the context of emerging markets in APAC, what are some of the opportunities and challenges that we see in clinical laboratories practices? The rapidly evolv...Read more
-
Innovent presents clinical data of Sintilimab
Clinical Research | News | 0 Comment | 20 Sep, 2018
Innovent Biologics, a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs presented clinical trial data on cohort D of sintilimab clinical ...Read more
-
CISCRP releases a video to improve diversity in clinical research
Clinical Research | News | 0 Comment | 19 Sep, 2018
The Center for Information and Study on Clinical Research Participation (CISCRP), a Boston-based nonprofit organization, announces a new video featuring an innovative program to increase aw...Read more
-
Daily intake of Aspirin has little effect on cardiovascular disease, says a study
Clinical Research | News | 0 Comment | 17 Sep, 2018
Three groundbreaking papers published in New England Journal of Medicine, led by a team of Monash University researchers in Melbourne, reveal the results from a seven-year study of the bene...Read more
-
Medtronic starts Onyx ONE Clear study in Japan and US
Clinical Research | News | 0 Comment | 14 Sep, 2018
Medtronic has initiated a new clinical study in patients implanted with its Resolute Onyx drug-eluting stent (DES) during percutaneous coronary intervention (PCI) procedures. The Onyx ONE ...Read more
-
Oryzon gets approval for conducting Phase IIa trial of Vafidemstat
Clinical Research | News | 0 Comment | 10 Sep, 2018
Oryzon Genomics, a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has announced the approval by the ...Read more
-
TB Alliance Launches Clinical Trial for New TB drug
Clinical Research | News | 0 Comment | 31 Aug, 2018
TB Alliance, a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight tuberculosis (TB) has initiated a pivotal clinical trial, SimpliciTB...Read more
-
NUS researchers uncover a bidirectional regulator in cancer cells
Clinical Research | News | 0 Comment | 20 Aug, 2018
Singapore - An in-depth study on the regulation of adenosine-to-inosine (A-to-I) RNA editing by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National Un...Read more
-
Tolero Pharmaceuticals collaborates with AbbVie for AML trial
Clinical Research | News | 0 Comment | 20 Aug, 2018
Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologic and oncologic diseases, has entered into a clinical research collab...Read more
-
HSA approves TCR immunotherapy trial for liver cancer
Clinical Research | News | 0 Comment | 20 Aug, 2018
Lion TCR Pte. Ltd., a Singapore-based Biotech company has received approval from Health Sciences Authority (HSA), Singapore, for its Phase I/II multi-centre clinical study of its product ca...Read more
-
FSD Pharma, SciCann Launch clinical research program in Israel
Clinical Research | News | 0 Comment | 17 Aug, 2018
FSD Pharma announced the launch of a clinical research collaborative program in Israel, via its strategic R&D partner, SciCann Therapeutics Inc. This comprehensive clinical resear...Read more
-
Kyowa Hakko Kirin announces results of Phase 3 trial of patients with Cutaneous T-cell Lymphoma
Clinical Research | News | 0 Comment | 13 Aug, 2018
Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) has announced that results of the global Phase 3 MAVORIC study (Mogamulizumab anti-CCR4 Antibody Versus ComparatOR In CTCL) investigating the use ...Read more
